Once-weekly glucagon-like peptide-1 receptor agonists vs dipeptidyl peptidase-4 inhibitors: cardiovascular effects in people with diabetes and cardiovascular disease.

Cardiovasc Diabetol · 2023 · PMC10662529 · PMID 37985992

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

marginally significantP = 0.050actually significant

However, no significant interactions were identified for HCRU and cost outcomes, except for a marginally significant interaction with all-cause hospitalizations ( P = 0.050; data not shown).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.